App Detail » BioRhythm-Breast

What's New

1.Fix known bugs
2.Optimize user experience

App Description

First one-stop home-based female breast-health monthly self-monitoring platform.

Breast cancer is the commonest cancer among females, with a high incidence and mortality rate, one in eight women has a lifetime chance of developing breast cancer. Only if medical screening such as mammography, is performed regularly, detection of early breast cancer is difficult to achieve.

Many studies have shown that the cure rate of breast cancer in early stage is more than 90%. In addition to regular medical check-up, professionals have suggested the best way to fight against breast cancer is through monthly self-examinations.

"BioRhythm" based on the fundamental theoretical research of many Nobel Prizes winners in Physiology or Medicine and the mechanism of abnormal cell metabolic heat. This fills in the international market void of "Cell Heat Release Rhythm" waveform home-assisted self-screening product. The established mathematical analysis model of "Multiple Biorhythms" applies AI technology to intelligently analyze the waveforms while eliminating "multiple interference factors", thereby improving the specificity of the biomarker of "Cell Metabolic Heat Release Rhythm" and achieving home health risk early warning. The smart sensor of the monitoring device, connect the continuously monitored data to the mobile phone APP via Bluetooth, and then transmit it to the cloud database of "Biorhythm" in real time for big data comparison and analysis. And after the system has completed analyzing the report will be sent to the user’s mobile phone.

Statement: Shanghai Testing & Inspection Institute for Medical Devices is commissioned to conduct test inspection, although the inspection report of "Biorhythm" (No.: the Chinese Medicine Examines (Supposes) Character 国医检（设）字QW2017 No. 1332) has stated its "clinical function", but this product still cannot be a substitute for any examination item carried out in medical institutions; it also does not replace the Chinese National Health Commission’s (NHC) guidelines for women to "conduct self-examination once a month" in the 2018 "Breast Cancer Diagnosis and Treatment Guidelines". This product is limited to home "assisted self-monitoring" aims to carry out early-warning management of health under the suspected abnormal state of "breast biorhythm". Users must seek qualified medical professions or doctor’s advice in addition to using this app and before making any medical decisions.

Note: Shanghai Testing & Inspection Institute for Medical Devices is the largest national-level medical device quality supervision and inspection agency; and designated laboratory for medical device product certification and testing in China and is itself reviewed and approved by The State Food and Drug Administration, China Quality Certification Center, and relevant departments etc.

**This App needs to be used with "Special Underwear” and “Devices”. For more details, please click on the link below.

https://www.hkbiorhythm.com

App Changes

• June 16, 2019 Initial release
• January 28, 2020 New version 2.0
• July 15, 2020 New version 2.6
• August 06, 2021 New version 2.8.8